Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol

Fertility and Sterility

Volumn 101, Issue 4, 2014, Pages 1008-1011

  Fatemi, Human Mousavi ^a   Popovic Todorovic, Biljana ^b   Humaidan, Peter ^c   Kol, Shahar ^d   Banker, Manish ^e   Devroey, Paul ^a   García Velasco, Juan Antonio ^f  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b Special Gynecology Hospital Ivanovic   (Serbia)

^c AARHUS UNIVERSITY   (Denmark)

^d RAMBAM MEDICAL CENTER   (Israel)

^e NOVAIVI   (India)

^f INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

freeze all; GnRH agonist triggering; GnRH antagonist; ovarian hyperstimulation syndrome

Indexed keywords

CABERGOLINE; CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ABDOMINAL DISTENSION; ABDOMINAL DRAINAGE; ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; BODY MASS; CASE REPORT; CONVALESCENCE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLOW UP; HEMOCONCENTRATION; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYSTEROSALPINGOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; LUTEAL PHASE; OMAN; OOCYTE RETRIEVAL; OVARY DISEASE; OVARY ENLARGEMENT; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PALLIATIVE THERAPY; PRIORITY JOURNAL; TERTIARY CARE CENTER; UNITED ARAB EMIRATES; URINE VOLUME;

FREEZE-ALL; GNRH AGONIST TRIGGERING; GNRH ANTAGONIST; OVARIAN HYPERSTIMULATION SYNDROME;

ADULT; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; TREATMENT OUTCOME;

EID: 84897128895     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.01.019     Document Type: Article

References (19)

1. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
2. R. Gómez, S.R. Soares, C. Busso, J.A. Garcia-Velasco, C. Simón, and A. Pellicer Physiology and pathology of ovarian hyperstimulation syndrome Semin Reprod Med 28 2010 448 457
3. C. Busso, J. Garcia-Velasco, R. Gómez, C. Álvarez, C. Simón, and A. Pellicer Update on prediction and management of OHSS. Prevention of OHSS - dopamine agonists Reprod Biomed Online 19 2009 43 51
4. D.D. Braat, J.M. Schutte, R.E. Bernardus, T.M. Mooij, and F.E. van Leeuwen Maternal death related to IVF in the Netherlands 1984-2008 Hum Reprod 25 2010 1782 1786
5. P. Humaidan, L. Bungum, M. Bungum, and C.Y. Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod Biomed Online 13 2006 173 178
6. S. Kol Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil Steril 81 2004 1 5
7. P. Humaidan, N.P. Polyzos, B. Alsbjerg, K. Erb, A.L. Mikkelsen, and H.O. Elbaek et al. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients Hum Reprod 28 2013 2511 2521
8. P. Devroey, N. Polyzos, and C. Bockell An OHSS-free clinic by segmentation of IVF treatment Hum Reprod 10 2011 2593 2597
9. S.S. Yen, O. Llerena, B. Little, and O.H. Pearson Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man J Clin Endocrinol Metab 28 1968 1763 1767
10. M.D. Damewood, W. Shen, H.A. Zacur, W.D. Schlaff, J.A. Rock, and E.E. Wallach Disappearance of exogenously administered human chorionic gonadotropin Fertil Steril 52 1989 398 400
11. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil Steril 56 1991 213 220
12. IVF Worldwide. Survey on vitrification, GnRH trigger and differed embryo transfer. Available at: www.ivf-worldwide.com/survey/vitrification-gnrh-trigger- and-differed-et.html. Accessed December 11, 2013.
13. J.C. Castillo, J. Garcia-Velasco, and P. Humaidan Empty follicle syndrome after GnRHa triggering in COS J Assist Reprod Genet 29 2012 249 253
14. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 29 2008 84 91
15. G. Griesinger, L. Schultz, T. Bauer, A. Broessner, T. Frambach, and S. Kissler Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin- releasing hormone antagonist protocol in combination with a 'freeze-all' strategy: a prospective multicentric study Fertil Steril 95 2011 2029 2033
16. S. Kol, and P. Humaidan GnRH agonist triggering: recent developments Reprod Biomed Online 26 2013 226 230
17. A. Seyhan, B. Ata, M. Polat, W.Y. Son, H. Yarali, and M.H. Dahan Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG Hum Reprod 28 2013 2522 2528
18. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod Biomed Online 18 2009 630 634
19. L. Montanelli, A. Delbaere, C. Di Carlo, C. Nappi, G. Smits, and G. Vassart et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome J Clin Endocrinol Metab 89 2004 1255 1258